Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-06-01 to 2024-04-30
Current total value of award: $9407618
Description: USAMMDA PHASE III SBIR